Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/52179
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Smith, B. | - |
dc.contributor.author | Chur-Hansen, A. | - |
dc.contributor.author | Neale, A. | - |
dc.contributor.author | Symon, J. | - |
dc.date.issued | 2008 | - |
dc.identifier.citation | Australasian Psychiatry, 2008; 16(6):433-437 | - |
dc.identifier.issn | 1039-8562 | - |
dc.identifier.issn | 1440-1665 | - |
dc.identifier.uri | http://hdl.handle.net/2440/52179 | - |
dc.description | Copyright © 2008 The Royal Australian and New Zealand College of Psychiatrists | - |
dc.description.abstract | <h4>Objectives</h4>Cholinesterase inhibitors' (ChEIs) impact on cognitive functioning in Alzheimer's disease has been extensively researched. The effect of ChEIs on improving day-to-day living and quality of life in conjunction with level of functioning for patients or their carers has not been investigated.<h4>Method</h4>Five spouse dyads (patient and carer) and one additional carer were interviewed about their perceptions of ChEIs in relation to their influence on daily life for both parties. Interviews were transcribed and thematic analysis conducted.<h4>Results</h4>Themes identified were forgetfulness, differences in long-term versus short-term memory, independence/dependence, negative emotion, no appreciable benefit, sense of hopelessness, carer as motivator, stabilization of the patient, and never regain what has been lost.<h4>Conclusions</h4>This study suggests that ChEI medication does not enhance life for the patient or their primary caregiver. Further qualitative and quantitative research is required into the impact of ChEIs upon both the patient and their caregivers. | - |
dc.description.statementofresponsibility | Bethany Smith, Anna Chur-Hansen, Alice Neale and Jonathon Symon | - |
dc.language.iso | en | - |
dc.publisher | Informa Healthcare-Taylor & Francis | - |
dc.source.uri | http://dx.doi.org/10.1080/10398560802375990 | - |
dc.subject | Humans | - |
dc.subject | Alzheimer Disease | - |
dc.subject | Cholinesterase Inhibitors | - |
dc.subject | Treatment Outcome | - |
dc.subject | Activities of Daily Living | - |
dc.subject | Product Surveillance, Postmarketing | - |
dc.subject | Emotions | - |
dc.subject | Motivation | - |
dc.subject | Mental Recall | - |
dc.subject | Interview, Psychological | - |
dc.subject | Cost of Illness | - |
dc.subject | Quality of Life | - |
dc.subject | Aged | - |
dc.subject | Aged, 80 and over | - |
dc.subject | Caregivers | - |
dc.subject | Patient Satisfaction | - |
dc.subject | South Australia | - |
dc.subject | Female | - |
dc.subject | Male | - |
dc.title | Quality of life and cholinesterase inhibitors: A qualitative study of patients with Alzheimer's Disease and their carers | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1080/10398560802375990 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Chur-Hansen, A. [0000-0002-2935-2689] | - |
Appears in Collections: | Aurora harvest Psychiatry publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.